This endeavour aligns with the objectives outlined in the Post COVID-19 Development Strategy (PCDS) 2030, which intends to empower the people of Sarawak with the necessary skills to access higher-paying job opportunities and boost their income levels.
CRC SGH is the first site in Malaysia to obtain Malaysia Ministry of Health (MoH) approval to undertake FIH clinical trials, having done so in November 2019.
This premise will eventually house not only the research centre with training facilities, but JKR Sarawak’s own ISO 17025 accredited Central Materials Laboratory will also be operating from there.
Malaysia witnessed the launching of the new Malaysian Research Accelerator for Technology and Innovation (MRANTI) Park Master Plan on 6 October by the Malaysian Prime Minister.
SGH will now become a centre of excellence in Malaysia for clinical trials – one that can cater for different phases of clinical trials, from FiH (First-in-Human) clinical trials to late phase clinical research.
Research, development, commercialization and innovation (R&D&C&I) plays a crucial role in fostering innovation and accelerating socioeconomic development towards ensuring a better quality of life.
Between 2017 to 2021, MARDI Sarawak’s rigorous research and development efforts resulted in some of the institute’s most beneficial innovations to Sarawak’s agriculture.
Since its formation in 2017, Sarawak Research and Development Council has been integral in enhancing the promotion, coordination and advancement of Sarawak’s research and development.